176 related articles for article (PubMed ID: 18450743)
21. Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant (MM5.2).
Van Riet I; De Greef C; Aharchi F; Woischwill C; De Waele M; Bakkus M; Lacor P; Schots R; Van Camp B
Leukemia; 1997 Feb; 11(2):284-93. PubMed ID: 9009094
[TBL] [Abstract][Full Text] [Related]
22. Candida albicans can stimulate stromal cells resulting in enhanced granulopoiesis.
Basu S; Zhang HH; Quilici C; Dunn AR
Stem Cells Dev; 2004 Feb; 13(1):39-50. PubMed ID: 15068692
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal stromal cell secretome up-regulates 47 kDa CXCR4 expression, and induce invasiveness in neuroblastoma cell lines.
Shankar V; Hori H; Kihira K; Lei Q; Toyoda H; Iwamoto S; Komada Y
PLoS One; 2015; 10(3):e0120069. PubMed ID: 25774696
[TBL] [Abstract][Full Text] [Related]
25. Functional interleukin-7 receptors (IL-7Rs) are expressed by marrow stromal cells: binding of IL-7 increases levels of IL-6 mRNA and secreted protein.
Iwata M; Graf L; Awaya N; Torok-Storb B
Blood; 2002 Aug; 100(4):1318-25. PubMed ID: 12149213
[TBL] [Abstract][Full Text] [Related]
26. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion.
Inohara H; Akahani S; Koths K; Raz A
Cancer Res; 1996 Oct; 56(19):4530-4. PubMed ID: 8813152
[TBL] [Abstract][Full Text] [Related]
27. Identification of an IL-7-associated pre-pro-B cell growth-stimulating factor (PPBSF). I. Production of the non-IL-7 component by bone marrow stromal cells from IL-7 gene-deleted mice.
McKenna SD; Chen F; Lai L; Goldschneider I
J Immunol; 1998 Mar; 160(5):2272-9. PubMed ID: 9498767
[TBL] [Abstract][Full Text] [Related]
28. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.
Nefedova Y; Landowski TH; Dalton WS
Leukemia; 2003 Jun; 17(6):1175-82. PubMed ID: 12764386
[TBL] [Abstract][Full Text] [Related]
30. Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells.
Shin HH; Kim SJ; Kang SY; Lee DS; Choi HS
Bone; 2006 Oct; 39(4):716-23. PubMed ID: 16750437
[TBL] [Abstract][Full Text] [Related]
31. GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
Peng Y; Li Z; Li Z
Biochem Biophys Res Commun; 2013 Nov; 440(4):558-63. PubMed ID: 24113381
[TBL] [Abstract][Full Text] [Related]
32. Galectin-3 initiates epithelial-stromal paracrine signaling to shape the proteolytic microenvironment during corneal repair.
AbuSamra DB; Mauris J; Argüeso P
Sci Signal; 2019 Jul; 12(590):. PubMed ID: 31311846
[TBL] [Abstract][Full Text] [Related]
33. Crosstalk between bone marrow-derived myofibroblasts and gastric cancer cells regulates cancer stemness and promotes tumorigenesis.
Zhu L; Cheng X; Shi J; Jiacheng L; Chen G; Jin H; Liu AB; Pyo H; Ye J; Zhu Y; Wang H; Chen H; Fang J; Cai L; Wang TC; Yang CS; Tu SP
Oncogene; 2016 Oct; 35(41):5388-5399. PubMed ID: 27109105
[TBL] [Abstract][Full Text] [Related]
34. The role of galectin-3 and galectin-3-binding protein in venous thrombosis.
DeRoo EP; Wrobleski SK; Shea EM; Al-Khalil RK; Hawley AE; Henke PK; Myers DD; Wakefield TW; Diaz JA
Blood; 2015 Mar; 125(11):1813-21. PubMed ID: 25428218
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44.
Cao JJ; Singleton PA; Majumdar S; Boudignon B; Burghardt A; Kurimoto P; Wronski TJ; Bourguignon LY; Halloran BP
J Bone Miner Res; 2005 Jan; 20(1):30-40. PubMed ID: 15619667
[TBL] [Abstract][Full Text] [Related]
36. Pre-B cell generation potentiated by soluble factors from a bone marrow stromal cell line.
Landreth KS; Dorshkind K
J Immunol; 1988 Feb; 140(3):845-52. PubMed ID: 3276783
[TBL] [Abstract][Full Text] [Related]
37. Effects of lipid mediators on the synthesis of leukaemia inhibitory factor and interleukin 6 by human bone marrow stromal cells.
Denizot Y; Trimoreau F; Praloran V
Cytokine; 1998 Oct; 10(10):781-5. PubMed ID: 9811531
[TBL] [Abstract][Full Text] [Related]
38. Sialoadhesin expression by bone marrow macrophages derived from Ehrlich-tumor-bearing mice.
Kusmartsev S; Ruiz de Morales JM; Rullas J; Danilets MG; Subiza JL
Cancer Immunol Immunother; 1999 Dec; 48(9):493-8. PubMed ID: 10602886
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats.
Wang FS; Wang CJ; Chen YJ; Huang YT; Huang HC; Chang PR; Sun YC; Yang KD
Endocrinology; 2004 May; 145(5):2148-56. PubMed ID: 14962990
[TBL] [Abstract][Full Text] [Related]
40. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
